I 
118TH CONGRESS 
2D SESSION 
H. R. 8247 
To authorize the Secretary of Health and Human Services to award grants 
to increase early detection of and intervention for uterine fibroids, and 
for other purposes. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 6, 2024 
Ms. BROWN (for herself, Ms. CLARKE of New York, Mrs. CHERFILUS-MCCOR-
MICK, Ms. LOIS FRANKEL of Florida, Mrs. BEATTY, Mr. JACKSON of Illi-
nois, Ms. NORTON, Ms. JACKSON LEE, Ms. KAMLAGER-DOVE, Ms. 
KELLY of Illinois, Mrs. HAYES, Mrs. TRAHAN, Mr. LIEU, Mr. FROST, 
Ms. STEVENS, Mrs. WATSON COLEMAN, Mrs. RAMIREZ, Ms. MOORE of 
Wisconsin, Ms. STRICKLAND, Ms. JACOBS, Mr. VEASEY, Ms. WILLIAMS 
of Georgia, Mr. GRIJALVA, Ms. JAYAPAL, Ms. PLASKETT, Ms. PRESSLEY, 
Ms. SEWELL, Mr. JOHNSON of Georgia, Mr. CASAR, Mrs. FOUSHEE, Ms. 
BLUNT ROCHESTER, Mr. CARSON, and Ms. BUDZINSKI) introduced the 
following bill; which was referred to the Committee on Energy and Com-
merce 
A BILL 
To authorize the Secretary of Health and Human Services 
to award grants to increase early detection of and inter-
vention for uterine fibroids, and for other purposes. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
VerDate Sep 11 2014 
03:41 Jun 01, 2024
Jkt 049200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H8247.IH
H8247
kjohnson on DSK7ZCZBW3PROD with $$_JOB
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Uterine Fibroid Inter-
vention and Gynecological Health Treatment Act of 
2024’’. 
SEC. 2. RESEARCH ON UTERINE FIBROID EARLY DETEC-
TION AND INTERVENTION. 
(a) IN GENERAL.—The Secretary of Health and 
Human Services (in this Act referred to as the ‘‘Sec-
retary’’) shall— 
(1) conduct or support research on increasing 
early detection of, and intervention for, uterine 
fibroids; and 
(2) based on the results of such research and 
other relevant information, formulate evidence-based 
or evidence-informed strategies to increase early de-
tection in health care settings. 
(b) TIMELINE.—The Secretary shall finalize the evi-
dence-based or evidence-informed strategies required by 
subsection (a)(2) as expeditiously as possible in order to 
make such strategies available to grantees under section 
3 to implement such strategies pursuant to section 
3(b)(3). 
SEC. 3. GRANTS WITH RESPECT TO UTERINE FIBROID 
EARLY DETECTION AND INTERVENTION. 
(a) IN GENERAL.—The Secretary of Health and 
Human Services (in this Act referred to as the ‘‘Sec-
VerDate Sep 11 2014 
03:41 Jun 01, 2024
Jkt 049200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H8247.IH
H8247
kjohnson on DSK7ZCZBW3PROD with $$_JOB
retary’’) may award grants to States for carrying out pro-
grams— 
(1) to increase early detection of and interven-
tion for uterine fibroids; and 
(2) to develop and implement public awareness 
and education campaigns for the early detection and 
intervention of uterine fibroids. 
(b) USE OF FUNDS.—A State receiving a grant under 
this section may use the grant, with respect to increasing 
early detection of and intervention for uterine fibroids, for 
the following activities: 
(1) Screening procedures, including advanced 
gynecological imaging (including payment therefor). 
(2) Patient navigation services. 
(3) Implementation of evidence-based or evi-
dence-informed strategies proven to increase early 
detection in health care settings. 
(4) Facilitating access to health care settings. 
(c) PRIORITY.—In awarding grants under this sec-
tion, the Secretary shall give priority to States proposing 
to carry out a program in a geographic areas in which 
there are socially vulnerable populations with elevated risk 
of uterine fibroid development. 
VerDate Sep 11 2014 
03:41 Jun 01, 2024
Jkt 049200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H8247.IH
H8247
kjohnson on DSK7ZCZBW3PROD with $$_JOB
SEC. 4. RESEARCH WITH RESPECT TO UTERINE FIBROID 
EARLY DETECTION AND INTERVENTION. 
The Secretary may award grants to conduct research, 
which may include clinical trials, related to— 
(1) disparities in pain control and management 
in uterine fibroid surgical treatment; or 
(2) Asherman’s Syndrome, intrauterine adhe-
sions, and other intrauterine conditions as deter-
mined appropriate by the Secretary. 
SEC. 5. REPORTS TO CONGRESS. 
(a) REPORTS ON GRANTS.—Not later 2 years after 
the initial award of grants under this Act, and every 2 
years thereafter, the Secretary shall submit to the Con-
gress, and make publicly available on the appropriate 
website of the Department of Health and Human Services, 
a report summarizing the findings and results of programs 
and activities funded through grants under this Act. 
(b) REPORT ON RESEARCH DEVELOPMENTS.—Not 
later than 2 years after the date of enactment of this Act, 
and every 2 years thereafter, the Secretary shall submit 
to the Congress, and make publicly available on the appro-
priate website of the Department of Health and Human 
Services, a report outlining research developments and 
findings related to— 
(2) disparities in pain control and management 
in uterine fibroid surgical treatment; and 
VerDate Sep 11 2014 
03:41 Jun 01, 2024
Jkt 049200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H8247.IH
H8247
kjohnson on DSK7ZCZBW3PROD with $$_JOB
(3) Asherman’s Syndrome, intrauterine adhe-
sions, and other intrauterine conditions as deter-
mined appropriate by the Secretary. 
Æ 
VerDate Sep 11 2014 
03:41 Jun 01, 2024
Jkt 049200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6301
E:\BILLS\H8247.IH
H8247
kjohnson on DSK7ZCZBW3PROD with $$_JOB